Please login to the form below

Not currently logged in


This page shows the latest NextCure news and features for those working in and with pharma, biotech and healthcare.

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly gained exclusive rights to license any targeted antibodies discovered through the platform, with NextCure also having this option. ... Last November, NextCure presented results from the phase 1 portion of its ongoing trial with NC318, its lead

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....